Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689813-20-000042
Filing Date
2020-05-07
Accepted
2020-05-07 17:16:49
Documents
84
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bhvn-20200331.htm   iXBRL 10-Q 1446097
2 EX-31.2 a2020q1bhvn10-qexh312.htm EX-31.2 16660
3 EX-32.1 a2020q1bhvn10-qexh321.htm EX-32.1 11027
4 EX-33.1 a2020q1bhvn10-qexh311.htm EX-33.1 16563
  Complete submission text file 0001689813-20-000042.txt   7455250

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20200331.xsd EX-101.SCH 64333
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhvn-20200331_cal.xml EX-101.CAL 76641
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20200331_def.xml EX-101.DEF 321924
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20200331_lab.xml EX-101.LAB 642301
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20200331_pre.xml EX-101.PRE 475255
86 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20200331_htm.xml XML 1247093
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38080 | Film No.: 20857647
SIC: 2834 Pharmaceutical Preparations